The DOI matches its Crossref record.
Epithelial-Mesenchymal Transitions in Cancer Progression
Abstract
Epithelial cells are the most important cell type in the development of human malignancies. More than 90% of all malignant tumors are carcinomas, and thus of epithelial origin. Aberrant growth and the ability to invade the underlying tissues are intrinsic properties of the fatally altered cells. Multiple genetic alterations that can influence growth and genetic stability of the carcinoma cells have been characterised during tumor progression. Loss of epithelial morphology and the acquisition of mesenchymal characteristics are typical for carcinoma cells late in tumor progression and correlate with metastatic potential. In vitro, epithelial-mesenchymal transitions can be induced by interference with the integrity of the adherens junction, by signalling via tyrosine kinases, and by oncogene expression. In carcinoma cells, loss or downregulation of E-cadherin expression are frequently observed in carcinomas, and correlate with the malignancy of the tumor. In general, this change in expression is regulated at the transcriptional level. However, tumor types or cell lines exist which show mesenchymal characteristics but nevertheless express E-cadherin protein or mRNA. A more-detailed analysis demonstrated that other mechanisms that interfere with E-cadherin-mediated cell adhesion can be operative. Mutations in the E-cadherin gene and loss or mutation of the second, intact copy as well as mutation in the catenin genes, which encode proteins that interact with the cytoplasmic portion of E-cadherin, can be observed. In addition, transient or unregulated phosphorylation by receptor tyrosine kinases or oncogenic tyrosine kinases, respectively, can interfere with the epithelial morphology and induce a mesenchymal conversion. Since tyrosine phosphorylation of β-catenin correlates with the epithelial-mesenchymal transition that is observed, E-cadherin-mediated cell adhesion might be modulated by such a mechanism. Interestingly, the same molecules implicated in the control of malignant properties turn out to play fundamental roles in the control of normal epithelial growth, differentiation and morphogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Extracellular matrix remodelling: the role of matrix metalloproteinases
Stamenkovic, I. (2003) · The Journal of Pathology · doi:10.1002/path.1400 · Cited by 1,140
The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis
Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J.-P., Gray, J. W., Pinkel, D., Bissell, M. J., & Werb, Z. (1999) · Cell · doi:10.1016/s0092-8674(00)81009-0 · Cited by 924
Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M., Berx, G., Cano, A., Beug, H., & Foisner, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208429 · Cited by 808
Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells
Yáñez-Mó, M., Lara-Pezzi, E., Selgas, R., Ramírez-Huesca, M., Domínguez-Jiménez, C., Jiménez-Heffernan, J. A., Aguilera, A., Sánchez-Tomero, J. A., Bajo, M. A., Álvarez, V., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020809 · Cited by 776
Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z., & Bissell, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1861 · Cited by 655
Mani, S. A., Yang, J., Brooks, M., Schwaninger, G., Zhou, A., Miura, N., Kutok, J. L., Hartwell, K., Richardson, A. L., & Weinberg, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703900104 · Cited by 575
The Fallacy of Epithelial Mesenchymal Transition in Neoplasia
Tarin, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0699 · Cited by 531
DIRECT EVIDENCE FOR A ROLE OF β‐CATENIN/LEF‐1 SIGNALING PATHWAY IN INDUCTION OF EMT
Kim, K., Lu, Z., & Hay, E. D. (2002) · Cell Biology International · doi:10.1006/cbir.2002.0901 · Cited by 428
N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Nakajima, S., Doi, R., Toyoda, E., Tsuji, S., Wada, M., Koizumi, M., Tulachan, S. S., Ito, D., Kami, K., Mori, T., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0578-03 · Cited by 427
Autocrine PDGFR signaling promotes mammary cancer metastasis
Jechlinger, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24652 · Cited by 371
Stockinger, A., Eger, A., Wolf, J., Beug, H., & Foisner, R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104036 · Cited by 335
Moreno-Bueno, G., Cubillo, E., Sarrió, D., Peinado, H., Rodríguez-Pinilla, S. M., Villa, S., Bolós, V., Jordá, M., Fabra, A., Portillo, F., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0479 · Cited by 320
Protein kinase CK2 in mammary gland tumorigenesis
Landesman-Bollag, E., Romieu-Mourez, R., Song, D. H., Sonenshein, G. E., Cardiff, R. D., & Seldin, D. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204411 · Cited by 289
Grosheva, I., Shtutman, M., Elbaum, M., & Bershadsky, A. D. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.4.695 · Cited by 282
Petit, V., Boyer, B., Lentz, D., Turner, C. E., Thiery, J. P., & Vallés, A. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.5.957 · Cited by 279
Orford, K., Orford, C. C., & Byers, S. W. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.4.855 · Cited by 276
Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells
Bagnoli, F., Buti, L., Tompkins, L., Covacci, A., & Amieva, M. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502598102 · Cited by 266
IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition
Morali, O. G., Delmas, V., Moore, R., Jeanney, C., Thiery, J. P., & Larue, L. (2001) · Oncogene · doi:10.1038/sj.onc.1204660 · Cited by 264
Cheng, S., & Lovett, D. H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64327-1 · Cited by 258
The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
Sternlicht, M. D., Bissell, M. J., & Werb, Z. (2000) · Oncogene · doi:10.1038/sj.onc.1203347 · Cited by 256
E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium
Auersperg, N., Pan, J., Grove, B. D., Peterson, T., Fisher, J., Maines-Bandiera, S., Somasiri, A., & Roskelley, C. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6249 · Cited by 254
Eyden, B. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00213.x · Cited by 252
Cannito, S., Novo, E., di Bonzo, L. V., Busletta, C., Colombatto, S., & Parola, M. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2737 · Cited by 239
“A first point is that many of the pathways that the literature associates with tumor progression seem to converge on Ecadherin downregulation, considered as a critical event in the development of metastasis in most if not all epithelial tumours (15, 20, 201); accordingly, the loss of E-cadherin expression in sporadic…”
Influential
Metadata
- Authors
- Birchmeier, C., Birchmeier, W., & Brand-Saberi, B.
- Venue
- Cells Tissues Organs
- Publisher
- S. Karger AG
- Published
- 1996
- Volume
- 156
- Issue
- 3
- Pages
- 217-226
- ISSN
- 1422-6405 (ISSN-L)
- 1422-6421
- OpenAlex
- W2083487959
- Cited by
- 268
- References
- 0
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.